Large-scale testing (Phase 3)Study completedNCT01916252
What this trial is testing
Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old
Who this might be right for
Multiple Myeloma
PETHEMA Foundation 460